BMI-1 Blocking Peptide Summary
| Description |
A peptide to BMI1.
|
| Specificity |
This peptide is specific for NB110-40823 only.
|
| Protein/Peptide Type |
Blocking Peptide
|
| Gene |
BMI1
|
Applications/Dilutions
| Application Notes |
This peptide is useful as a blocking peptide for NB 110-40823.For further blocking peptide related protocol, click here.
|
Packaging, Storage & Formulations
| Storage |
Store at -80C. Avoid freeze-thaw cycles.
|
| Buffer |
Peptide dissolved in dH2O. Contains no BSA.
|
| Preservative |
No Preservative
|
| Concentration |
1.0 mg/ml
|
Alternate Names for BMI-1 Blocking Peptide
- B lymphoma Mo-MLV insertion region 1 homolog (mouse)
- B lymphoma Mo-MLV insertion region 1 homolog
- BMI1 polycomb ring finger oncogene
- BMI1
- BMI-1
- FLVI2/BMI1
- MGC12685
- murine leukemia viral (bmi-1) oncogene homolog
- PCGF4
- polycomb complex protein BMI-1
- polycomb group protein Bmi1
- polycomb group ring finger 4
- RING finger protein 51
- RNF51
- RNF51Polycomb group RING finger protein 4
Background
The Bmi1 oncogene induces telomerase activity and immortalizes human mammary epithelial cells. Bmi1 extends the replicative life span of human fibroblasts by suppressing the p16-dependent senescence pathway.